Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care

International Journal of Clinical Practice

Volumn 63, Issue 3, 2009, Pages 439-448

  Belsey, J D ^a,d   Pittard, J B ^b   Rao, S ^c   Urdahl, H ^d   Jameson, K ^d   Dixon, T ^a  

^a JB Medical Ltd   (United Kingdom)

^b Soar Beyond Limited ^*

^c Merck Sharp & Dohme Limited   (United Kingdom)

^d JB Medical Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DIET THERAPY; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIET; DRUG THERAPY, COMBINATION; EXERCISE; GREAT BRITAIN; GUIDELINE ADHERENCE; HEALTH EXPENDITURES; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; THIAZOLIDINEDIONES;

EID: 59349105682     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01992.x     Document Type: Article

References (54)

1. Khan AI, Vasquez Y, Gray J, Wians FH Jr., Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 2006 130 : 1527 32.
2. NHS Business Services Authority. The Electronic Drug Tariff. http://www.ppa.org.uk/edt/February-2007/mindex.htm (accessed 7/2/07)
3. Prescription Cost Analysis: England 2006-7. http://www.ic.nhs.uk/ statistics-and-data-collections/primary-care/prescriptions/prescription-cost- analysis-2007 (accessed 21/5/08).
4. Prescription Cost Analysis: Wales 2006-7. http://www.wales.nhs.uk/sites3/ page.cfm?orgid=428&pid=13533. Accessed 21/5/08
5. Prescription Cost Analysis: Scotland 2006-7. http://isd.scot.nhs.uk/isd/ information-and-statistics.jsp?pContentID=2241&p-applic=CCC&p-service= Content.show (accessed 21/5/08).
6. Prescription Cost Analysis: Northern Ireland 2006-7. http://www. centralservicesagency.com/display/statistics (accessed 21/5/08).
7. Diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 86.
8. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993 329 : 304 9.
9. Worth R, Home PD, Johnston DG et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. BMJ 1982 285 : 1233 40.
10. Carney RM, Schechter K, Homa M, Levandoski L, White N et al. The effects of blood glucose testing versus urine sugar testing on the metabolic control of insulin-dependent diabetic children. Diabet Care 1983 6 : 378 80.
11. Miller PF, Stratton C, Tripp JH. Blood testing compared with urine testing in the long term control of diabetes. Arch Dis Child 1983 58 : 294 7.
12. Mann NP, Noronha SR, Johnston DL. A prospective study to evaluate the benefits of long term self-monitoring of blood glucose in diabetic children. Diabet Care 1984 7 : 322 6.
13. Terent A, Hagfall O, Cederholm U. The effect of education and self-monitoring of blood glucose on glycosylated hemoglobin in type I diabetes. A controlled 18-month trial in a representative population. Acta Med Scand 1985 217 : 47 53.
14. Daneman D, Siminerio L, Transue D, Betschart J, Drash A et al. The role of self-monitoring of blood glucose in the routine management of children with insulin-dependent diabetes mellitus. Diabet Care 1985 8 : 1 4.
15. Gordon D, Semple CG, Paterson KR. Do different frequencies of self-monitoring of blood glucose influence control in type 1 diabetic patients? Diabet Med 1991 8 : 679 82.
16. Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jorgens V et al. Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow - blood glucose versus urine glucose self-monitoring. Diabetologia 1994 37 : 170 6.
17. Coster S, Gulliford MC, Seed P, Powrie JK, Swaminathan R. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess 2000 4 : i 93.
18. Royal College of Physicians. Type 1 Diabetes in Adults: National Clinical Guideline for Diagnosis and Management in Primary Care. Section 6.2 Self-Monitoring of Blood Glucose. London : Royal College of Physicians, 2004.
19. IDF Clinical Guidelines Taskforce. Global Guideline for Type 2 Diabetes. Section 8: Self-Monitoring. Brussels: International Diabetes Federation, 2005.
20. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 1998 352 : 837 53.
21. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34. Lancet 1998 352 : 854 65.
22. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008 25 : 245 54.
23. Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. BMJ 2007 335 : 493 8.
24. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991 260 : E67 74.
25. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabet Care 1997 20 : 135 41.
26. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab 1989 15 : 255 60.
27. Rutten G, van Eijk J, de Nobel E, Beek M, van der Velden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract 1990 7 : 273 8.
28. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabet Care 1990 13 : 1044 50.
29. Estey AL, Tan MH, Mann K. Follow-up intervention: its effect on compliance behavior to a diabetes regimen. Diabetes Educ 1990 16 : 291 5.
30. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994 31 : 215 9.
31. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996 30 : 238 43.
32. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabet Care 2002 25 : 1928 32.
33. Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003 29 : 587 94.
34. Kwon HS, Cho JH, Kim HS, Song BR, Ko SH et al. Establishment of blood glucose monitoring system using the internet. Diabet Care 2004 27 : 478 83.
35. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005 118 : 422 5.
36. 1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabet Care 2006 29 : 2625 31.
37. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005 2 : CD005060.
38. Sarol JN Jr., Nicodemus NA Jr., Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 2005 21 : 173 84.
39. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006 295 : 1688 97.
40. Farmer A, Wade A, Goyder E, Yudkin P, French D et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007 335 : 132 6.
41. Simon J, Gray A, Clarke O, Wade A, Neil A et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008 336 : 1177 80.
42. O'Kane MJ, Bunting B, Copeland M, Coates VE, on behalf of the ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008 336 : 1174 7.
43. Farmer A, Balman E, Gadsby R, Moffat J, Cradock S et al. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events. Curr Med Res Opin 2008 24 : 3097 104.
44. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabet Care 2008 31 (Suppl. 1 S12 54.
45. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006 49 : 1711 21.
46. International Diabetes Federation. Guideline for Management of Postmeal Glucose. http://www.idf.org/ (accessed 21 May 2008).
47. National Institute for Health and Clinical Excellence. Type 2 Diabetes: The Management of Type 2 Diabetes. Clinical Guideline 66. London : NICE, May 2008.
48. Owens D, Barnett AH, Pickup J, Kerr D, Bushby P et al. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes Prim Care 2004 6 : 8 15.
49. Owens D, Pickup J, Barnett A et al. The continuing debate on self-monitoring of blood glucose. Diabetes Prim Care 2005 7 : 9 21.
50. Quality and Outcomes Framework 2006-7. Raw data output by PCT: Target DM1. http://www.gpcontract.co.uk/download.php?year=7 (accessed 21/5/08).
51. IMS Disease Analyzer, as interpreted by MSD: February 2008.
52. Lawrenson RA, Coles G, Walton K et al. Characteristics of practices contributing to the MediPlus database and the implications for its use in epidemiological research. J Inform Prim Care 1998 May 14 8.
53. Monthly Index of Medical Specialties. London : Haymarket Medical Media Ltd. June 2008.
54. Reynolds RM, Strachan MW. Home blood glucose monitoring in type 2 diabetes. BMJ 2004 329 : 755 6.